# A Study of Idazoxan in Healthy Participants

> **NCT05727189** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Terran Biosciences Australia Pty Ltd** · enrollment: 150 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** TR-01-XRR (1)
- **DRUG:** TR-01-XRR (2)
- **DRUG:** TR-01-XRR (3)
- **DRUG:** TR-01-XRS
- **DRUG:** TR-01-XR
- **DRUG:** TR-01-IR
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05727189
- **Lead sponsor:** Terran Biosciences Australia Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-02-14
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05727189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05727189, "A Study of Idazoxan in Healthy Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05727189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*